
Dopamine-boosting drugs can reduce the neuroinflammation of depression
Atlanta: A new study conducted at Emory University in the United States has found that dopamine in the brain (feel-good and mood-enhancing hormone)-enhancing drugs have the potential to reduce neuroinflammation associated with depression. In several laboratories around the world, inflammation has been shown to affect the brain’s ‘reward pathways’, leading to low mood and anhedonia…